Medpace Holdings Stock Performance
| MEDP Stock | USD 446.17 17.99 4.20% |
The company secures a Beta (Market Risk) of 0.82, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medpace Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Medpace Holdings is expected to be smaller as well. At this point, Medpace Holdings has a negative expected return of -0.43%. Please make sure to verify Medpace Holdings' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Medpace Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Medpace Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in March 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return 4.2 | Five Day Return 5.87 | Year To Date Return (21.86) | Ten Year Return 1.5 K | All Time Return 1.5 K |
1 | Medpace Holdings, Inc. MEDP Shares Bought by Abacus FCF Advisors LLC - MarketBeat | 12/30/2025 |
2 | Medpace Holdings Valuation Check After Strong Growth In Clinical Research Demand And AI Analytics | 01/16/2026 |
3 | Mawer Investment Management Ltd. Sells 170,658 Shares of Medpace Holdings, Inc. MEDP | 02/02/2026 |
4 | Medpace Q4 Earnings Snapshot | 02/09/2026 |
5 | Oppenheimer Asset Management Inc. Has 18.49 Million Stock Holdings in Medpace Holdings, Inc. MEDP | 02/10/2026 |
6 | Medpace Holdings Margin Compression Tests Bullish Earnings Growth Narrative In FY 2025 | 02/11/2026 |
7 | Assessing Medpace Holdings Valuation After Recent Share Price Pullback | 02/12/2026 |
8 | Medpace Holdings, Inc. Just Reported, And Analysts Assigned A US491 Price Target | 02/13/2026 |
| Begin Period Cash Flow | 669.4 M | |
| Total Cashflows From Investing Activities | -31.1 M |
Medpace Holdings Relative Risk vs. Return Landscape
If you would invest 59,182 in Medpace Holdings on November 21, 2025 and sell it today you would lose (14,565) from holding Medpace Holdings or give up 24.61% of portfolio value over 90 days. Medpace Holdings is currently does not generate positive expected returns and assumes 2.8719% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Medpace, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Medpace Holdings Target Price Odds to finish over Current Price
The tendency of Medpace Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 446.17 | 90 days | 446.17 | close to 99 |
Based on a normal probability distribution, the odds of Medpace Holdings to move above the current price in 90 days from now is close to 99 (This Medpace Holdings probability density function shows the probability of Medpace Stock to fall within a particular range of prices over 90 days) .
Medpace Holdings Price Density |
| Price |
Predictive Modules for Medpace Holdings
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medpace Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medpace Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medpace Holdings Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Medpace Holdings is not an exception. The market had few large corrections towards the Medpace Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medpace Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medpace Holdings within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.44 | |
β | Beta against Dow Jones | 0.82 | |
σ | Overall volatility | 48.81 | |
Ir | Information ratio | -0.16 |
Medpace Holdings Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medpace Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medpace Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medpace Holdings generated a negative expected return over the last 90 days | |
| Medpace Holdings is unlikely to experience financial distress in the next 2 years | |
| Medpace Holdings currently holds 250.5 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Medpace Holdings has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Medpace Holdings' use of debt, we should always consider it together with its cash and equity. | |
| Medpace Holdings has a very strong financial position based on the latest SEC filings | |
| Over 86.0% of Medpace Holdings shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Citi Raises Becton Dickinson PT to 198 after Life Sciences Sale Update |
Medpace Holdings Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medpace Stock often depends not only on the future outlook of the current and potential Medpace Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medpace Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.5 M | |
| Cash And Short Term Investments | 497 M |
Medpace Holdings Fundamentals Growth
Medpace Stock prices reflect investors' perceptions of the future prospects and financial health of Medpace Holdings, and Medpace Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medpace Stock performance.
| Return On Equity | 0.7 | ||||
| Return On Asset | 0.16 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 11.76 B | ||||
| Shares Outstanding | 28.38 M | ||||
| Price To Earning | 49.07 X | ||||
| Price To Book | 26.46 X | ||||
| Price To Sales | 4.80 X | ||||
| Revenue | 2.53 B | ||||
| Gross Profit | 1.8 B | ||||
| EBITDA | 570.5 M | ||||
| Net Income | 451.12 M | ||||
| Cash And Equivalents | 31.01 M | ||||
| Cash Per Share | 1.00 X | ||||
| Total Debt | 250.5 M | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 0.41 X | ||||
| Book Value Per Share | 16.18 X | ||||
| Cash Flow From Operations | 713.22 M | ||||
| Earnings Per Share | 15.30 X | ||||
| Market Capitalization | 12.15 B | ||||
| Total Asset | 1.98 B | ||||
| Retained Earnings | (459.98 M) | ||||
| Working Capital | (354.12 M) | ||||
| Current Asset | 94.72 M | ||||
| Current Liabilities | 134.02 M | ||||
About Medpace Holdings Performance
Assessing Medpace Holdings' fundamental ratios provides investors with valuable insights into Medpace Holdings' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Medpace Holdings is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.01 | 0.01 | |
| Return On Tangible Assets | 0.35 | 0.37 | |
| Return On Capital Employed | 0.85 | 0.89 | |
| Return On Assets | 0.23 | 0.24 | |
| Return On Equity | 0.98 | 1.03 |
Things to note about Medpace Holdings performance evaluation
Checking the ongoing alerts about Medpace Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medpace Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medpace Holdings generated a negative expected return over the last 90 days | |
| Medpace Holdings is unlikely to experience financial distress in the next 2 years | |
| Medpace Holdings currently holds 250.5 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Medpace Holdings has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Medpace Holdings' use of debt, we should always consider it together with its cash and equity. | |
| Medpace Holdings has a very strong financial position based on the latest SEC filings | |
| Over 86.0% of Medpace Holdings shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Citi Raises Becton Dickinson PT to 198 after Life Sciences Sale Update |
- Analyzing Medpace Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medpace Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Medpace Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medpace Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medpace Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medpace Holdings' stock. These opinions can provide insight into Medpace Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.